Hahnemann has been scaling back services since announcing in June that it would close Sept. 6. The hospital pushed back the closure date after a bankruptcy judge approved the sale of its residency programs on Sept. 5.
Hahnemann’s owners initially agreed to sell its residency slots to West Reading, Pa.-based Tower Health for $7.5 million. However, six health systems teamed up to bid $55 million for the residency programs on Aug. 9. Three Philadelphia-based health systems — Einstein Healthcare Network, Jefferson Health and Temple University Health System — joined forces with Bryn Mawr, Pa.-based Main Line Health, Camden, N.J.-based Cooper University Health Care and Wilmington, Del.-based Christiana Care Health System to place the winning bid.
More articles on healthcare finance:
Hospital profitability up after significant declines in June, Kaufman Hall finds
Fitch: Nonprofit hospital margins improve for first time since 2016
For-profit operator to close Nix Medical Center in San Antonio
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
